Aureomycin® from Zoetis Now Labeled for Bacterial Pneumonia Control in Dairy Heifers

Additional label claim allows dairy producers to use Aureomycin for a wider range of indications under a veterinary feed directive

PARSIPPANY, N.J., July 3, 2019 — Dairy producers can now add Aureomycin® from Zoetis to replacement heifer feed for control of bacterial pneumonia. This expanded label provides another option against costly pneumonia for veterinarians and dairy producers.

This label update recently approved by the U.S. Food and Drug Administration allows for this feed additive to be fed to dairy replacement heifers at a rate of 350 milligrams per head per day with a veterinary feed directive (VFD) from a licensed veterinarian. 

“Aureomycin has been a flexible and reliable control for bacterial pneumonia [caused by Pasteurella spp. susceptible to chlortetracycline] for many years,” said Aubrey Schroeder, PhD, associate director, regulatory affairs at Zoetis. “Veterinarians and dairy producers can now use Aureomycin for this added indication in dairy replacement heifers and take advantage of a zero-day withdrawal period to help keep heifers healthy.” 

Respiratory disease is one of the leading health concerns impacting dairy operations. It can reduce average daily gain of calves and heifers, which can lead to reproductive challenges, later calving ages that significantly impact profitability and decrease future milk production.1

“A VFD is required to feed rations with Aureomycin, but with a valid veterinarian-client-patient relationship, this process is simple and worth that added benefit to your herd,” Dr. Schroeder said. “This update for Aureomycin has already been added to electronic VFD forms.” 

Dairy producers are encouraged to contact their veterinarian for more information about Aureomycin. You also can learn more about the product here

Click to download the product logo and a high-resolution image of a feed bag for Aureomycin 50 Granular A.

Do not use Aureomycin in calves to be processed for veal.

Caution: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

About Zoetis 
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2018, the company generated annual revenue of $5.8 billion with approximately 10,000 employees. For more information, visit

For further information, contact:
Kathleen McGinty

Dorothy Tate
Bader Rutter

Van der Fels-Klerx HJ, Martin SW, Nielen M, Huirne RBM. Effects on productivity and risk factors of bovine respiratory disease in dairy heifers; a review for the Netherlands. Neth J Agri Sci. 2002;50(1):27-45.



Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2022 Zoetis Services LLC. All rights reserved.